Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 1 art units • 1 examiners • 0 of 4 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Cellanome Inc. has 4 pending office actions in Biotechnology & Pharmaceuticals. These actions are assigned among 2 distinct examiners and 2 distinct art units, so the reported workload spans multiple prosecution contacts rather than one examiner or one unit.
HORLICK, KENNETH R is the busiest examiner, handling 3 pending actions. The concentration with this examiner makes that relationship an immediate prosecution-management priority, while the remaining action involves a different examiner and art unit. A coordinated review of HORLICK matters may help identify recurring issues, amendment positions, or response timing that do not necessarily carry across the separate assignment.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §112 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HORLICK, KENNETH R | 4 | 79.0% | +15.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19577221 | METHODS FOR PERFORMING ASSAYS ON INDIVIDUAL LIVE CELLS | HORLICK, KENNETH R | — |
| 19381382 | DEVICES AND METHODS FOR ANALYZING BIOLOGICAL SAMPLES | HORLICK, KENNETH R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19684891 | METHODS FOR ENCLOSING AND ANALYZING A CELL IN A FLUIDIC DEVICE | HORLICK, KENNETH R | — |
| 19577221 | METHODS FOR PERFORMING ASSAYS ON INDIVIDUAL LIVE CELLS | HORLICK, KENNETH R | — |
| 19538691 | METHODS FOR INCUBATING AND ANALYZING A CELL IN A COMPARTMENT OF A FLUIDIC DEVICE | HORLICK, KENNETH R | — |
| 19381382 | DEVICES AND METHODS FOR ANALYZING BIOLOGICAL SAMPLES | HORLICK, KENNETH R | — |
| Art Unit | Apps |
|---|---|
| 1681 | 4 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19684891 | METHODS FOR ENCLOSING AND ANALYZING A CELL IN A FLUIDIC DEVICE | HORLICK, KENNETH R | 1681 | §112 | Non-Final OA | — | Pending | May 21, 2026 |
| 19577221 | METHODS FOR PERFORMING ASSAYS ON INDIVIDUAL LIVE CELLS | HORLICK, KENNETH R | 1681 | §102§103 | Final Rejection | — | Pending | Mar 24, 2026 |
| 19538691 | METHODS FOR INCUBATING AND ANALYZING A CELL IN A COMPARTMENT OF A FLUIDIC DEVICE | HORLICK, KENNETH R | 1681 | §103 | Non-Final OA | — | Pending | Feb 12, 2026 |
| 19381382 | DEVICES AND METHODS FOR ANALYZING BIOLOGICAL SAMPLES | HORLICK, KENNETH R | 1681 | §102§103 | Non-Final OA | — | Pending | Nov 06, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCellanome Inc. has 4 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Kenneth R Horlick has the most, with 4 of Cellanome Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
